The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global PARP Inhibitor Biomarkers Testing Product Market Research Report 2025
Synopsis
The global PARP Inhibitor Biomarkers Testing Product market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for PARP Inhibitor Biomarkers Testing Product is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PARP Inhibitor Biomarkers Testing Product is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of PARP Inhibitor Biomarkers Testing Product include Myriad Genetics, Inc., Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc. and BPS Bioscience, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PARP Inhibitor Biomarkers Testing Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PARP Inhibitor Biomarkers Testing Product.
Report Scope
The PARP Inhibitor Biomarkers Testing Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PARP Inhibitor Biomarkers Testing Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PARP Inhibitor Biomarkers Testing Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Myriad Genetics, Inc.
Hoffmann-La Roche AG
Invitae Corporation
NeoGenomics Laboratories, Inc.
BPS Bioscience, Inc.
Segment by Type
Testing Kits
Testing Assays
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PARP Inhibitor Biomarkers Testing Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PARP Inhibitor Biomarkers Testing Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global PARP Inhibitor Biomarkers Testing Product market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for PARP Inhibitor Biomarkers Testing Product is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PARP Inhibitor Biomarkers Testing Product is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of PARP Inhibitor Biomarkers Testing Product include Myriad Genetics, Inc., Hoffmann-La Roche AG, Invitae Corporation, NeoGenomics Laboratories, Inc. and BPS Bioscience, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for PARP Inhibitor Biomarkers Testing Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PARP Inhibitor Biomarkers Testing Product.
Report Scope
The PARP Inhibitor Biomarkers Testing Product market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PARP Inhibitor Biomarkers Testing Product market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PARP Inhibitor Biomarkers Testing Product manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Myriad Genetics, Inc.
Hoffmann-La Roche AG
Invitae Corporation
NeoGenomics Laboratories, Inc.
BPS Bioscience, Inc.
Segment by Type
Testing Kits
Testing Assays
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PARP Inhibitor Biomarkers Testing Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PARP Inhibitor Biomarkers Testing Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 PARP Inhibitor Biomarkers Testing Product Market Overview
1.1 Product Overview and Scope of PARP Inhibitor Biomarkers Testing Product
1.2 PARP Inhibitor Biomarkers Testing Product Segment by Type
1.2.1 Global PARP Inhibitor Biomarkers Testing Product Market Value Comparison by Type (2024-2030)
1.2.2 Testing Kits
1.2.3 Testing Assays
1.3 PARP Inhibitor Biomarkers Testing Product Segment by Application
1.3.1 Global PARP Inhibitor Biomarkers Testing Product Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global PARP Inhibitor Biomarkers Testing Product Market Size Estimates and Forecasts
1.4.1 Global PARP Inhibitor Biomarkers Testing Product Revenue 2019-2030
1.4.2 Global PARP Inhibitor Biomarkers Testing Product Sales 2019-2030
1.4.3 Global PARP Inhibitor Biomarkers Testing Product Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 PARP Inhibitor Biomarkers Testing Product Market Competition by Manufacturers
2.1 Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Manufacturers (2019-2024)
2.2 Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Manufacturers (2019-2024)
2.3 Global PARP Inhibitor Biomarkers Testing Product Average Price by Manufacturers (2019-2024)
2.4 Global PARP Inhibitor Biomarkers Testing Product Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PARP Inhibitor Biomarkers Testing Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PARP Inhibitor Biomarkers Testing Product, Product Type & Application
2.7 PARP Inhibitor Biomarkers Testing Product Market Competitive Situation and Trends
2.7.1 PARP Inhibitor Biomarkers Testing Product Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PARP Inhibitor Biomarkers Testing Product Players Market Share by Revenue
2.7.3 Global PARP Inhibitor Biomarkers Testing Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PARP Inhibitor Biomarkers Testing Product Retrospective Market Scenario by Region
3.1 Global PARP Inhibitor Biomarkers Testing Product Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global PARP Inhibitor Biomarkers Testing Product Global PARP Inhibitor Biomarkers Testing Product Sales by Region: 2019-2030
3.2.1 Global PARP Inhibitor Biomarkers Testing Product Sales by Region: 2019-2024
3.2.2 Global PARP Inhibitor Biomarkers Testing Product Sales by Region: 2025-2030
3.3 Global PARP Inhibitor Biomarkers Testing Product Global PARP Inhibitor Biomarkers Testing Product Revenue by Region: 2019-2030
3.3.1 Global PARP Inhibitor Biomarkers Testing Product Revenue by Region: 2019-2024
3.3.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Region: 2025-2030
3.4 North America PARP Inhibitor Biomarkers Testing Product Market Facts & Figures by Country
3.4.1 North America PARP Inhibitor Biomarkers Testing Product Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America PARP Inhibitor Biomarkers Testing Product Sales by Country (2019-2030)
3.4.3 North America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PARP Inhibitor Biomarkers Testing Product Market Facts & Figures by Country
3.5.1 Europe PARP Inhibitor Biomarkers Testing Product Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe PARP Inhibitor Biomarkers Testing Product Sales by Country (2019-2030)
3.5.3 Europe PARP Inhibitor Biomarkers Testing Product Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PARP Inhibitor Biomarkers Testing Product Market Facts & Figures by Country
3.6.1 Asia Pacific PARP Inhibitor Biomarkers Testing Product Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Country (2019-2030)
3.6.3 Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America PARP Inhibitor Biomarkers Testing Product Market Facts & Figures by Country
3.7.1 Latin America PARP Inhibitor Biomarkers Testing Product Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America PARP Inhibitor Biomarkers Testing Product Sales by Country (2019-2030)
3.7.3 Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Market Facts & Figures by Country
3.8.1 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Sales by Country (2019-2030)
3.8.3 Middle East and Africa PARP Inhibitor Biomarkers Testing Product Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PARP Inhibitor Biomarkers Testing Product Sales by Type (2019-2030)
4.1.1 Global PARP Inhibitor Biomarkers Testing Product Sales by Type (2019-2024)
4.1.2 Global PARP Inhibitor Biomarkers Testing Product Sales by Type (2025-2030)
4.1.3 Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2019-2030)
4.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Type (2019-2030)
4.2.1 Global PARP Inhibitor Biomarkers Testing Product Revenue by Type (2019-2024)
4.2.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Type (2025-2030)
4.2.3 Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type (2019-2030)
4.3 Global PARP Inhibitor Biomarkers Testing Product Price by Type (2019-2030)
5 Segment by Application
5.1 Global PARP Inhibitor Biomarkers Testing Product Sales by Application (2019-2030)
5.1.1 Global PARP Inhibitor Biomarkers Testing Product Sales by Application (2019-2024)
5.1.2 Global PARP Inhibitor Biomarkers Testing Product Sales by Application (2025-2030)
5.1.3 Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2019-2030)
5.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Application (2019-2030)
5.2.1 Global PARP Inhibitor Biomarkers Testing Product Revenue by Application (2019-2024)
5.2.2 Global PARP Inhibitor Biomarkers Testing Product Revenue by Application (2025-2030)
5.2.3 Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application (2019-2030)
5.3 Global PARP Inhibitor Biomarkers Testing Product Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Myriad Genetics, Inc.
6.1.1 Myriad Genetics, Inc. Corporation Information
6.1.2 Myriad Genetics, Inc. Description and Business Overview
6.1.3 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Product Portfolio
6.1.5 Myriad Genetics, Inc. Recent Developments/Updates
6.2 Hoffmann-La Roche AG
6.2.1 Hoffmann-La Roche AG Corporation Information
6.2.2 Hoffmann-La Roche AG Description and Business Overview
6.2.3 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Product Portfolio
6.2.5 Hoffmann-La Roche AG Recent Developments/Updates
6.3 Invitae Corporation
6.3.1 Invitae Corporation Corporation Information
6.3.2 Invitae Corporation Description and Business Overview
6.3.3 Invitae Corporation PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Invitae Corporation PARP Inhibitor Biomarkers Testing Product Product Portfolio
6.3.5 Invitae Corporation Recent Developments/Updates
6.4 NeoGenomics Laboratories, Inc.
6.4.1 NeoGenomics Laboratories, Inc. Corporation Information
6.4.2 NeoGenomics Laboratories, Inc. Description and Business Overview
6.4.3 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Product Portfolio
6.4.5 NeoGenomics Laboratories, Inc. Recent Developments/Updates
6.5 BPS Bioscience, Inc.
6.5.1 BPS Bioscience, Inc. Corporation Information
6.5.2 BPS Bioscience, Inc. Description and Business Overview
6.5.3 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Product Portfolio
6.5.5 BPS Bioscience, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PARP Inhibitor Biomarkers Testing Product Industry Chain Analysis
7.2 PARP Inhibitor Biomarkers Testing Product Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PARP Inhibitor Biomarkers Testing Product Production Mode & Process
7.4 PARP Inhibitor Biomarkers Testing Product Sales and Marketing
7.4.1 PARP Inhibitor Biomarkers Testing Product Sales Channels
7.4.2 PARP Inhibitor Biomarkers Testing Product Distributors
7.5 PARP Inhibitor Biomarkers Testing Product Customers
8 PARP Inhibitor Biomarkers Testing Product Market Dynamics
8.1 PARP Inhibitor Biomarkers Testing Product Industry Trends
8.2 PARP Inhibitor Biomarkers Testing Product Market Drivers
8.3 PARP Inhibitor Biomarkers Testing Product Market Challenges
8.4 PARP Inhibitor Biomarkers Testing Product Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global PARP Inhibitor Biomarkers Testing Product Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global PARP Inhibitor Biomarkers Testing Product Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global PARP Inhibitor Biomarkers Testing Product Market Competitive Situation by Manufacturers in 2023
Table 4. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Manufacturers (2019-2024)
Table 6. Global PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global PARP Inhibitor Biomarkers Testing Product Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market PARP Inhibitor Biomarkers Testing Product Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of PARP Inhibitor Biomarkers Testing Product, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of PARP Inhibitor Biomarkers Testing Product, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PARP Inhibitor Biomarkers Testing Product, Product Type & Application
Table 12. Global Key Manufacturers of PARP Inhibitor Biomarkers Testing Product, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PARP Inhibitor Biomarkers Testing Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PARP Inhibitor Biomarkers Testing Product as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PARP Inhibitor Biomarkers Testing Product Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global PARP Inhibitor Biomarkers Testing Product Sales by Region (2019-2024) & (K Units)
Table 18. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2019-2024)
Table 19. Global PARP Inhibitor Biomarkers Testing Product Sales by Region (2025-2030) & (K Units)
Table 20. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2025-2030)
Table 21. Global PARP Inhibitor Biomarkers Testing Product Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2019-2024)
Table 23. Global PARP Inhibitor Biomarkers Testing Product Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2025-2030)
Table 25. North America PARP Inhibitor Biomarkers Testing Product Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America PARP Inhibitor Biomarkers Testing Product Sales by Country (2019-2024) & (K Units)
Table 27. North America PARP Inhibitor Biomarkers Testing Product Sales by Country (2025-2030) & (K Units)
Table 28. North America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe PARP Inhibitor Biomarkers Testing Product Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe PARP Inhibitor Biomarkers Testing Product Sales by Country (2019-2024) & (K Units)
Table 32. Europe PARP Inhibitor Biomarkers Testing Product Sales by Country (2025-2030) & (K Units)
Table 33. Europe PARP Inhibitor Biomarkers Testing Product Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe PARP Inhibitor Biomarkers Testing Product Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America PARP Inhibitor Biomarkers Testing Product Sales by Country (2019-2024) & (K Units)
Table 42. Latin America PARP Inhibitor Biomarkers Testing Product Sales by Country (2025-2030) & (K Units)
Table 43. Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America PARP Inhibitor Biomarkers Testing Product Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Type (2019-2024)
Table 51. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Type (2025-2030)
Table 52. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2019-2024)
Table 53. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Type (2025-2030)
Table 54. Global PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Type (2019-2024)
Table 55. Global PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Type (2025-2030)
Table 56. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type (2019-2024)
Table 57. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Type (2025-2030)
Table 58. Global PARP Inhibitor Biomarkers Testing Product Price (US$/Unit) by Type (2019-2024)
Table 59. Global PARP Inhibitor Biomarkers Testing Product Price (US$/Unit) by Type (2025-2030)
Table 60. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Application (2019-2024)
Table 61. Global PARP Inhibitor Biomarkers Testing Product Sales (K Units) by Application (2025-2030)
Table 62. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2019-2024)
Table 63. Global PARP Inhibitor Biomarkers Testing Product Sales Market Share by Application (2025-2030)
Table 64. Global PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Application (2019-2024)
Table 65. Global PARP Inhibitor Biomarkers Testing Product Revenue (US$ Million) by Application (2025-2030)
Table 66. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application (2019-2024)
Table 67. Global PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Application (2025-2030)
Table 68. Global PARP Inhibitor Biomarkers Testing Product Price (US$/Unit) by Application (2019-2024)
Table 69. Global PARP Inhibitor Biomarkers Testing Product Price (US$/Unit) by Application (2025-2030)
Table 70. Myriad Genetics, Inc. Corporation Information
Table 71. Myriad Genetics, Inc. Description and Business Overview
Table 72. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Myriad Genetics, Inc. PARP Inhibitor Biomarkers Testing Product Product
Table 74. Myriad Genetics, Inc. Recent Developments/Updates
Table 75. Hoffmann-La Roche AG Corporation Information
Table 76. Hoffmann-La Roche AG Description and Business Overview
Table 77. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Hoffmann-La Roche AG PARP Inhibitor Biomarkers Testing Product Product
Table 79. Hoffmann-La Roche AG Recent Developments/Updates
Table 80. Invitae Corporation Corporation Information
Table 81. Invitae Corporation Description and Business Overview
Table 82. Invitae Corporation PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Invitae Corporation PARP Inhibitor Biomarkers Testing Product Product
Table 84. Invitae Corporation Recent Developments/Updates
Table 85. NeoGenomics Laboratories, Inc. Corporation Information
Table 86. NeoGenomics Laboratories, Inc. Description and Business Overview
Table 87. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. NeoGenomics Laboratories, Inc. PARP Inhibitor Biomarkers Testing Product Product
Table 89. NeoGenomics Laboratories, Inc. Recent Developments/Updates
Table 90. BPS Bioscience, Inc. Corporation Information
Table 91. BPS Bioscience, Inc. Description and Business Overview
Table 92. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. BPS Bioscience, Inc. PARP Inhibitor Biomarkers Testing Product Product
Table 94. BPS Bioscience, Inc. Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. PARP Inhibitor Biomarkers Testing Product Distributors List
Table 98. PARP Inhibitor Biomarkers Testing Product Customers List
Table 99. PARP Inhibitor Biomarkers Testing Product Market Trends
Table 100. PARP Inhibitor Biomarkers Testing Product Market Drivers
Table 101. PARP Inhibitor Biomarkers Testing Product Market Challenges
Table 102. PARP Inhibitor Biomarkers Testing Product Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PARP Inhibitor Biomarkers Testing Product
Figure 2. Global PARP Inhibitor Biomarkers Testing Product Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global PARP Inhibitor Biomarkers Testing Product Market Share by Type in 2023 & 2030
Figure 4. Testing Kits Product Picture
Figure 5. Testing Assays Product Picture
Figure 6. Global PARP Inhibitor Biomarkers Testing Product Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global PARP Inhibitor Biomarkers Testing Product Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global PARP Inhibitor Biomarkers Testing Product Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global PARP Inhibitor Biomarkers Testing Product Market Size (2019-2030) & (US$ Million)
Figure 13. Global PARP Inhibitor Biomarkers Testing Product Sales (2019-2030) & (K Units)
Figure 14. Global PARP Inhibitor Biomarkers Testing Product Average Price (US$/Unit) & (2019-2030)
Figure 15. PARP Inhibitor Biomarkers Testing Product Report Years Considered
Figure 16. PARP Inhibitor Biomarkers Testing Product Sales Share by Manufacturers in 2023
Figure 17. Global PARP Inhibitor Biomarkers Testing Product Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest PARP Inhibitor Biomarkers Testing Product Players: Market Share by Revenue in 2023
Figure 19. PARP Inhibitor Biomarkers Testing Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global PARP Inhibitor Biomarkers Testing Product Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2019-2030)
Figure 22. North America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2019-2030)
Figure 23. U.S. PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2019-2030)
Figure 26. Europe PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2019-2030)
Figure 27. Germany PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific PARP Inhibitor Biomarkers Testing Product Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Region (2019-2030)
Figure 34. China PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2019-2030)
Figure 45. Latin America PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2019-2030)
Figure 46. Mexico PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa PARP Inhibitor Biomarkers Testing Product Revenue Market Share by Country (2019-2030)
Figure 51. Turkey PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE PARP Inhibitor Biomarkers Testing Product Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of PARP Inhibitor Biomarkers Testing Product by Type (2019-2030)
Figure 55. Global Revenue Market Share of PARP Inhibitor Biomarkers Testing Product by Type (2019-2030)
Figure 56. Global PARP Inhibitor Biomarkers Testing Product Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of PARP Inhibitor Biomarkers Testing Product by Application (2019-2030)
Figure 58. Global Revenue Market Share of PARP Inhibitor Biomarkers Testing Product by Application (2019-2030)
Figure 59. Global PARP Inhibitor Biomarkers Testing Product Price (US$/Unit) by Application (2019-2030)
Figure 60. PARP Inhibitor Biomarkers Testing Product Value Chain
Figure 61. PARP Inhibitor Biomarkers Testing Product Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
